Compare BNR & MEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | MEI |
|---|---|---|
| Founded | 2014 | 1946 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.7M | 398.2M |
| IPO Year | 2019 | 1994 |
| Metric | BNR | MEI |
|---|---|---|
| Price | $9.02 | $11.62 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 10.1K | ★ 1.3M |
| Earning Date | 06-05-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | N/A | ★ 49.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $908,300,000.00 |
| Revenue This Year | $111.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 11.24 |
| 52 Week Low | $2.80 | $4.88 |
| 52 Week High | $41.72 | $15.55 |
| Indicator | BNR | MEI |
|---|---|---|
| Relative Strength Index (RSI) | 20.79 | 61.25 |
| Support Level | $7.99 | $6.67 |
| Resistance Level | $9.70 | $15.55 |
| Average True Range (ATR) | 1.17 | 1.34 |
| MACD | -0.72 | 0.00 |
| Stochastic Oscillator | 2.40 | 38.15 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.